Insider Transactions in Q1 2022 at Genocea Biosciences, Inc. (GNCA)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2022
|
Girish N Aakalu CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
2,397
-3.08%
|
$2,397
$1.1 P/Share
|
|
Mar 16
2022
|
William D Clark President and CEO |
SELL
Open market or private sale
|
Direct |
11,435
-2.97%
|
$11,435
$1.1 P/Share
|
|
Mar 16
2022
|
Thomas Andrew Davis CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,717
-3.77%
|
$2,717
$1.1 P/Share
|
|
Mar 16
2022
|
Diantha Duvall CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,873
-3.0%
|
$2,873
$1.1 P/Share
|
|
Mar 16
2022
|
Jessica Baker Flechtner Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,349
-3.32%
|
$3,349
$1.1 P/Share
|
|
Mar 15
2022
|
Girish N Aakalu CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
31,250
+28.65%
|
-
|
|
Mar 15
2022
|
William D Clark President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+28.05%
|
-
|
|
Mar 15
2022
|
Thomas Andrew Davis CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
31,250
+30.23%
|
-
|
|
Mar 15
2022
|
Diantha Duvall CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+28.17%
|
-
|
|
Mar 15
2022
|
Jessica Baker Flechtner Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,750
+30.28%
|
-
|
|
Mar 15
2022
|
Raymond D Stapleton Jr CHIEF TECHNOLOGY OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
43,750
+48.61%
|
-
|
|
Mar 15
2022
|
Jacquelyn L Sumer CHIEF LEGAL & COMPLIANCE OFF |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+45.18%
|
-
|